TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-253 Cr | ₹319 Cr | ₹30 Cr | ₹-175 Cr | ₹-95 Cr |
What is the latest Net Cash Inflow / Outflow ratio of TORRENT PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-253 Cr |
| Mar2024 | ₹319 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹-175 Cr |
| Mar2021 | ₹-95 Cr |
How is Net Cash Inflow / Outflow of TORRENT PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-253 Cr | Negative | |
| Mar2024 | ₹319 Cr | 955.47 | |
| Mar2023 | ₹30 Cr | Positive | |
| Mar2022 | ₹-175 Cr | Negative | |
| Mar2021 | ₹-95 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹139,278.7 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
| MANKIND PHARMA | ₹93,582.0 Cr | 5.8% | 13.4% | -11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.7% |
-3.6% |
27.4% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses